Form 8-K - Current report:
SEC Accession No. 0001193125-24-078910
Filing Date
2024-03-27
Accepted
2024-03-27 16:57:54
Documents
15
Period of Report
2024-03-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d817534d8k.htm   iXBRL 8-K 37317
2 EX-99.1 d817534dex991.htm EX-99.1 16219
6 GRAPHIC g817534g0327212403129.jpg GRAPHIC 4509
  Complete submission text file 0001193125-24-078910.txt   194009

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mack-20240327.xsd EX-101.SCH 2830
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mack-20240327_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mack-20240327_pre.xml EX-101.PRE 11248
19 EXTRACTED XBRL INSTANCE DOCUMENT d817534d8k_htm.xml XML 3680
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35409 | Film No.: 24791623
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)